Intraoperative Imaging of Pulmonary Adenocarcinoma
Phase of Trial: Phase I
Latest Information Update: 30 May 2016
Price : $35 *
At a glance
- Drugs Folate-fluorescein isothiocyanate conjugate (Primary)
- Indications Lung cancer; Thoracic neoplasms
- Focus Diagnostic use
- 16 May 2016 Status changed from recruiting to completed.
- 30 Oct 2015 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov.
- 30 Oct 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov.